Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026 Improved balance sheet through multiple direct offerings; completed payments of outstanding debt HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced full year 2025 financial results and provided a corporate update. Recent Highlights Secured both public and private Human Research Ethics Committee (HREC) approvals in Australia for a Phase 1/2 clinical trial evaluating CYWC628 for the treatment of refractory diabetic foot ulcers...

NEWBURYPORT, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported 2025 net income of $68.3 million, 15.8% higher than net income of $59.0 million for 2024. Adjusted net income grew 12.7% to $76.1 million. Net sales for the year ended December 31, 2025 were $602.8 million, 19.5% higher than 2024 sales of $504.4 million. GAAP and adjusted earnings per diluted common share outstanding (“EPS”) for the year ended December 31, 2025 were $8.75 and $9.76, respectively. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted gross margin, adjusted operating income, adjusted SG&A, adjusted net income and EPS, and EBITDA...

Reported positive update from Phase 2 CRDF-004 trial in first-line RAS-mutated mCRC, with the 30 mg onvansertib + FOLFIRI/bev arm demonstrating:• Robust ORR of 72.2% (vs 43.2% with combined SoC of FOLFOX/bev and FOLFIRI/bev)• Significant improvement in PFS over combined SoC (HR: 0.37, p

         Net Income per Diluted Share of $0.99 for the Fourth Quarter and $10.84 for the Full Year of 2025 Core FFO per Share of $1.40 for the Fourth Quarter and $6.68 for the Full Year of 2025         North America Same Property NOI increased by 7.9% for the Fourth Quarter and 5.7% for the Full Year of 2025         Acquired 14 MH and RV Communities for $457.0 million and Distributed Over $1.5 Billion of Capital to Shareholders, Inclusive of Cash Distributions and Share Repurchases in 2025         Establishing Guidance for 2026, Expecting: Core FFO per Share of $6.83 to $7.03 North American Same Property NOI Growth of 4.5% at the Midpoint; and UK Same Property NOI Growth of 2.2% at the Midpoint         Southfield, MI, Feb. 24, 2026 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company”...

– Initial 2026 AFFO Guidance of $1.39 to $1.41 per diluted share –– Initial 2026 Acquisition Volume Guidance of $115 Million to $125 Million –– Subsequently Expanded Aggregate Unsecured Credit Facilities by $115 Million to $555 Million –– Subsequent $44.2 Million of Equity Sales via ATM Program – CEDARHURST, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,200 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, today announced results for the quarter and year ended December 31, 2025. Highlights for the Quarter Ended December 31, 2025Acquired 65 USPS properties for approximately...

PALO ALTO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) — HP (NYSE: HPQ)First quarter GAAP diluted net earnings per share (“EPS”) of $0.58, down 1.7% from the prior year periodFirst quarter non-GAAP diluted net EPS of $0.81, up 9.5% from the prior year periodFirst quarter net revenue of $14.4 billion, up 6.9% from the prior-year periodFirst quarter net cash provided by operating activities of $383 million, free cash flow of $175 millionFirst quarter returned $0.6 billion to shareholders in the form of share repurchases and dividendsHP Inc.’s fiscal 2026 first quarter financial performance    Q1 FY26   Q1 FY25   Y/YGAAP net revenue ($B)   $ 14.4     $ 13.5     6.9  %GAAP operating margin     5.3 %     6.3 %   (1.0) ptsGAAP net earnings ($B)   $ 0.5     $ 0.6     (4 )%GAAP...

HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — Archrock, Inc. (NYSE: AROC) (“Archrock” or the “Company”) today reported results for the fourth quarter and full year 2025. Fourth Quarter and Full Year 2025 HighlightsRevenue for the fourth quarter of 2025 was $377.1 million compared to $326.4 million in the fourth quarter of 2024. Revenue for 2025 was $1,489.8 million compared to $1,157.6 million in 2024. Net income for the fourth quarter of 2025 was $116.8 million and EPS was $0.67, an increase of approximately 95% and 97%, respectively, compared to $59.8 million and $0.34, respectively, in the fourth quarter of 2024. Net income for 2025 was $322.3 million and EPS was $1.83, compared to $172.2 million and $1.05, respectively, in 2024. Adjusted net income (a non-GAAP measure defined below) for the fourth quarter of 2025 was $118.3 million...

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025:Worldwide net sales were $826.4 million, an increase of 25.7%, or an increase of 24.7% on a constant currency basis. Base business, excluding Nevro, net sales were $726.7 million, an increase of 10.6%, or an increase of 9.4% on a constant currency basis. GAAP net income for the quarter was $140.6 million. GAAP diluted earnings per share (“EPS”) was $1.03, an increase of 442.6%. Non-GAAP diluted EPS was $1.28, an increase of 52.1%.Full Year 2025:Worldwide net sales were $2,938.9 million, an increase of 16.7%, or an increase of 16.2% on a constant currency basis. Base business,...

FORT WORTH, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) — RANGE RESOURCES CORPORATION (NYSE: RRC) today announced its fourth quarter 2025 financial results and plans for 2026. Full-Year 2025 Highlights –Cash flow from operating activities of $1.2 billion Cash flow from operations, before working capital changes, of $1.3 billion Signed 10-year supply agreement for 75 Mmcf per day for a Midwest power plant Production averaged 2.24 Bcfe per day, comprised of approximately 69% natural gas All-in capital spending of $674 million, or $0.83 per mcfe Pre-hedge NGL realizations of $24.15 per barrel – premium of $0.87 over the Mont Belvieu equivalent Proved reserves of 18.1 Tcfe with positive performance revisions for the 18th consecutive year Debt to EBITDAX of 0.8x (Non-GAAP) at year-end 2025 Expect to maintain Net Zero Scope 1 and 2 GHG...

HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the fourth quarter and twelve months ended December 31, 2025.Net income attributable to Par Pacific stockholders of $77.7 million, or $1.53 per diluted share, for the fourth quarter and $369.4 million, or $7.16 per diluted share, for the full year Adjusted Net Income attributable to Par Pacific stockholders of $59.5 million, or $1.17 per diluted share, for the fourth quarter and $390.1 million, or $7.56 per diluted share, for the full year Adjusted EBITDA of $113.1 million for the fourth quarter and $633.5 million for the full year Repurchased 0.7 million shares in the fourth quarter, bringing total 2025 repurchases to 6.5 million shares at an average price of approximately...